Alembic Pharma

Alembic Pharmaceuticals Ltd Key Ratios

NSEBSE

₹982.7

(-0.72%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Alembic Pharmaceuticals Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Growth matrix (%)
Revenue growth	17.09	17.05	25.67	-0.12
Op profit growth	27.35	39.99	35.83	4.52
EBIT growth	29.27	39.45	40.95	1.93
Net profit growth	42.14	41.83	41.62	2.34
Profitability ratios (%)
OPM	28.88	26.55	22.2	20.54
EBIT margin	25.66	23.24	19.51	17.39
Net profit margin	21.84	17.99	14.85	13.17
RoCE	25.3	23.56	21.82	21.23
RoNW	7.1	6.97	5.91	5
RoA	5.38	4.56	4.15	4.02
Per share ratios (₹)
EPS	56.72	42.47	31.44	22.33
Dividend per share	14	10	5.5	4
Cash EPS	50.6	35.62	24.88	16.29
Book value per share	257.77	170.77	144.22	117.76
Valuation ratios
P/E	17.01	12.56	16.87	24.55
P/CEPS	19.07	14.98	21.31	33.65
P/B	3.74	3.12	3.67	4.65
EV/EBIDTA	12.4	9.54	12.37	16.84
Payout (%)
Dividend payout	0	0	0	18.27
Tax payout	-18.51	-19.08	-20.91	-22.23
Liquidity ratios
Debtor days	41.05	53.63	47.09	50.43
Inventory days	90.47	85.38	78.9	79.66
Creditor days	-65.42	-74.17	-87.14	-92.43
Leverage ratios
Interest coverage	-86.39	-39.41	-41.7	-160.19
Net debt / equity	0.09	0.51	0.33	0.27
Net debt / op. profit	0.3	1.36	1.05	0.96
Cost breakup (₹)
Material costs	-23.31	-22.56	-25.22	-28.28
Employee costs	-19.49	-19.68	-18.97	-19.89
Other costs	-28.31	-31.19	-33.59	-31.28